Efficacy of Dan’e Fukang Soft Extract in Moderate Ovarian Hyperstimulation Syndrome for Concurrent Treatment of Blood and Fluid Guided by the “Triple Prevention” Principle

References

• Schirmer DA, Kulkarni AD, Zhang Y, et al. Ovarian hyperstimulation syndrome after assisted reproductive technologies: trends, predictors, and pregnancy outcomes. Fertil Steril. 2020;114(3):567–578. doi:10.1016/j.fertnstert.2020.04.004
   PubMed Web of Science ®Google Scholar
• Şanlı C, Atilgan R, Kuloğlu T, et al. Transient receptor potential melastatin 2 ion channel activity in ovarian hyperstimulation syndrome physiopathology. Turk J Med Sci. 2021;51(2):787–795. doi:10.3906/sag-2005-297
   PubMed Web of Science ®Google Scholar
• Rizk B, Aboulghar M, Smitz J, Ron-El R. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. Human Reproduction Update. 1997;3(3):255–266. doi:10.1093/humupd/3.3.255
   PubMed Web of Science ®Google Scholar
• Pala Ş, Atilgan R, Ozkan ZS, et al. Effect of varying doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome: an experimental study. Drug Des Devel Ther. 2015;9:1761–176
   PubMed Web of Science ®Google Scholar
• Kumar P, Sait SF, Sharma A, Kumar M. Ovarian hyperstimulation syndrome. J Hum Reprod Sci. 2011;4(2):70–75. doi:10.4103/0974-1208.86080
   PubMedGoogle Scholar
• Tang H, Hunter T, Hu Y, Zhai SD, Sheng X, Hart RJ. Cabergoline for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev. 2012;15:CD008605.
   Google Scholar
• Şanlı C, Atılgan R, Kuloğlu T, et al. The investigation of cholinergic receptor muscarinic 1 activity in the rat ovary with induced ovarian hyperstimulation. Turk J Obstet Gynecol. 2023;20(1):53–58. doi:10.4274/tjod.galenos.2023.75336
   PubMed Web of Science ®Google Scholar
• Tso LO, Costello MF, Albuquerque LE, Andriolo RB, Macedo CR. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2014;CD006105. doi:10.1002/14651858.CD006105.pub3
   PubMed Web of Science ®Google Scholar
• Jacob SL, Brewer C, Tang T, Picton HM, Barth JH, Balen AH. A short course of metformin does not reduce OHSS in a GnRH antagonist cycle for women with PCOS undergoing IVF: a randomised placebo-controlled trial. Hum Reprod. 2016;31:2756–2764. doi:10.1093/humrep/dew268
   PubMed Web of Science ®Google Scholar
• Boothroyd C, Karia S, Andreadis N, Rombauts L, Johnson N, Chapman M. Consensus statement on prevention and detection of ovarian hyperstimulation syndrome. Aust N Z J Obstet Gynaecol. 2015;55(6):523–534. doi:10.1111/ajo.12406
   PubMed Web of Science ®Google Scholar
• Pfeifer S, Butts S, Dumesic D; Practice Committee of the American Society for Reproductive Medicine. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Sterility. 2016;106(7):1634–1647. doi:10.1016/j.fertnstert.2016.08.048
   PubMed Web of Science ®Google Scholar
• Atilgan R, Pala Ş, Yavuzkır Ş, et al. What is the impact of short- and long-term supplementation of either cabergoline or clarithromycin on resolving rat ovarian hyperstimulation syndrome (OHSS) model? J Obstet Gynaecol. 2019;39(5):687–694. doi:10.1080/01443615.2018.1563774
   PubMedGoogle Scholar
• Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update. 2002;8(6):559–577. doi:10.1093/humupd/8.6.559
   PubMed Web of Science ®Google Scholar
• Xie X, Gou W. Gynecology and Obstetrics [M]. 7th ed. Beijing: People’s Medical Publishing House; 2013:249.
   Google Scholar
• KODAMAN PH. Current strategies for endometriosis management. Obstet Gynecol Clin North Am. 2015;42(1):87–101. doi:10.1016/j.ogc.2014.10.005
   PubMed Web of Science ®Google Scholar
• Zhu J, Zhong LY. Application of Dan’e Fukang soft extracts in the clinical treatment of endometriosis. Jilin J Chin Med. 2016;36(07):700–702.
   Google Scholar
• Zhang ST. Clinical observation of danazol combined with reverse addition method in the treatment of endometriosis. Hebei Med J. 2013;35(15):2304–2305.
   Google Scholar
• Zhang CE, Li JY. Observation on the therapeutic effect of Danshen Fukan decoction on endometriosis. Shi Zhen Guo Yi Guo Yao. 2008;19(6):1478–1479.
   Google Scholar
• Kim JJ, Kurita T, Bulun SE. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev. 2013;34(1):130–162. doi:10.1210/er.2012-1043
   PubMed Web of Science ®Google Scholar
• Zhi W. A qualitative study of the perception of experience during the treatment period in patients with endometriosis. J Qilu Nurs. 2015;21(14):10–12.
   Google Scholar
• He M, Zhou Y, Liu F. Systematic review on the efficacy and safety of Danfukang soft extracts in the treatment of endometriosis. Chin J Hospital Pharm. 2012;32(07):528–534.
   Google Scholar
• Yao L, Xie L, Gong Z, et al. Clinical study on prevention of ovarian hyperstimulation syndrome with wenyang lishuihuoxue prescription. Chin J Mod Drug App. 2020;14(11):198–200.
   Google Scholar
• Deng LW, Mu L. Discussing the application of blood and water treatment strategy in ovarian hyperstimulation syndrome from the perspective of ”blood disorder causes retained water”. New Chin Med. 2014;46(04):8–10.
   Google Scholar
• Teng Y. Analysis of ovarian hyperstimulation syndrome from traditional Chinese medicine perspective. J Jiangxi Tradit Chin Med. 2010;41(3):8–10.
   Google Scholar
• Xu XH, Chen YC, Xu YL, et al. Garcinone E blocks autophagy through lysosomal functional destruction in ovarian cancer cells. World J Tradit Chin Med. 2021;7:209–216.
   Google Scholar
• Hu YX, Zhang ZQ, Zhou QJ, Liao JY, Chai XL. Mechanism exploration of the classical traditional Chinese medicine formula huoluo xiaoling pill in clinical treatment and the traditional Chinese medicine theory “treating different diseases with the same method”: a network pharmacology study and molecular docking verification. World J Tradit Chin Med. 2022;8:131–140.
   Google Scholar
• Liang X. Research progress of traditional Chinese medicine in the treatment of threatened abortion. J Tradit Chin Med. 2012;27(12):1663–1665.
   Google Scholar
• Ismet H, Elif K, Gokay O, et al. Oxytocin and cabergoline alleviate ovarian hyperstimulation syndrome (OHSS) by suppressing vascular endothelial growth factor (VEGF) in an experimental model. Arch Gynecol Obstet. 2021;303(4):1099–1108. doi:10.1007/s00404-020-05855-1
   PubMed Web of Science ®Google Scholar
• Raoul O, Olga DS, Daniel L, et al. Interleukin-2 and SOCS-1 proteins involvement in the pathophysiology of severe ovarian hyperstimulation syndrome--a preliminary proof of concept. J Ovarian Res. 2014;7:106. doi:10.1186/s13048-014-0106-2
   PubMed Web of Science ®Google Scholar
• Sergio RS, Raul G, Carlos S, et al. Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome. Hum Reprod Update. 2008;14(4):321–333. doi:10.1093/humupd/dmn008
   PubMed Web of Science ®Google Scholar
• Scott MN. Prevention and management of ovarian hyperstimulation syndrome. Thromb Res. 2017;151 Suppl 1:S61–S64. doi:10.1016/S0049-3848(17)30070-1
   PubMed Web of Science ®Google Scholar